Responses

Download PDFPDF

Duodenal adenomatosis in familial adenomatous polyposis
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Authors reply to Drs. Latchford and Phillips
    • Steffen Bülow, Consultant surgeon
    • Other Contributors:
      • Jan Björk, Ib J. Christensen, Olav Fausa, Heikki Järvinen, Flemming Moesgaard, and Hans F.A. Vasen

    Dear Editor

    This letter is in response to the letter by Latchford and Phillips.[1]

    We agree that the ideal upper endoscopy for evaluation of duodenal adenomatosis in FAP should be performed with a side viewing as well as a forward viewing endoscope, but as pointed out by Latchford & Phillips we underlined and discussed this problem in our article.[2] Our Nordic- Dutch study was planned in the late 1...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Duodenal adenoma and cancer in FAP

    Dear Editor

    We congratulate the authors on gathering this large cohort of patients in this important area in FAP but would like to express some reservations with regards the study. Our first concern relates to the means of endoscopic assessment. Standard forward viewing endoscopy was used, whereas in clinical practice side viewing endoscopy is recommended since duodenal polyposis in FAP is more severe in the peria...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Authors reply to Dr Biasco et al.

    Dear Editor

    This letter is in response to the letter by Biasco et al.[1]

    In our study [2] of 368 patients with a median follow-up of 91 months the cumulative incidence of duodenal adenomatosis Spigelman stage IV was 52% at age 70, which is in fact almost the same life time risk as the 50% found by Saurin et al.[3] and 20-30% in the Swedish and Finnish series.[4,5]

    In conclusion, all major...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    The risk of duodenal cancer in patients with Familial Adenomatous Polyposis
    • Guido Biasco, Professor
    • Other Contributors:
      • Maria A. Pantaleo, Giulio Di Febo, Carlo Calabrese and Giovanni Brandi

    Dear Editor

    Bülow and coworkers published the results of a prospective multicenter study addressed to the analysis of the natural history of duodenal adenomas in Familial Adenomatous Polyposis (FAP).[1]

    368 patients were examined in a mean period of 7.6 years (range 0.5-10.4). They show a significative progression of Spigelman stage over time (p< 0.0001). At the end of the study the incidence of Spigel...

    Show More
    Conflict of Interest:
    None declared.